PTPN11 and neuroblastoma: We further confirmed this drug data by analyzing genetic screens with RNAi of 648 solid tumor cancer cell lines (Figure S2B), demonstrating an enhanced sensitivity to SHP2 small interfering RNA (siRNA) in the RAS/RAF WT NB cell lines, and one not appreciated in the RAS/RAF mt NB cell lines.